scholarly article | Q13442814 |
review article | Q7318358 |
P6179 | Dimensions Publication ID | 1004897302 |
P356 | DOI | 10.1186/1471-2474-15-27 |
P932 | PMC publication ID | 3926680 |
P698 | PubMed publication ID | 24444047 |
P5875 | ResearchGate publication ID | 259824916 |
P2093 | author name string | Casilda M Balmaceda | |
P2860 | cites work | Health-related quality of life in older adults with symptomatic hip and knee osteoarthritis: a comparison with matched healthy controls. | Q51924187 |
Prevalence and burden of osteoarthritis: results from a population survey in Norway. | Q53158014 | ||
Nonsteroidal antiinflammatory drug gastropathy: we started it, why don't we stop it? | Q53291067 | ||
Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population | Q81491619 | ||
Co-morbidities of patients with knee osteoarthritis | Q83991040 | ||
Pharmacological management of persistent pain in older persons | Q84159023 | ||
Targeting the synovial tissue for treating osteoarthritis (OA): where is the evidence? | Q37686658 | ||
Should nonsteroidal anti-inflammatory drugs (NSAIDs) be prescribed to the older adult? | Q37794972 | ||
Safety profile of topical diclofenac: a meta-analysis of blinded, randomized, controlled trials in musculoskeletal conditions | Q37828160 | ||
What of guidelines for osteoarthritis? | Q37868774 | ||
Topical therapies for osteoarthritis | Q37902642 | ||
Effectiveness and safety of topical versus oral nonsteroidal anti-inflammatory drugs: a comprehensive review | Q38109089 | ||
Treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. | Q38133481 | ||
Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee. | Q39358260 | ||
Diclofenac metabolic profile following in vitro percutaneous absorption through viable human skin | Q41747044 | ||
Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers | Q43258644 | ||
Diclofenac sodium gel in patients with primary hand osteoarthritis: a randomized, double-blind, placebo-controlled trial | Q43300193 | ||
Review of the pharmaceutical properties and clinical effects of the topical NSAID formulation, diclofenac epolamine | Q43539645 | ||
Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk | Q44627113 | ||
Efficacy and safety of 5% ibuprofen cream treatment in knee osteoarthritis. Results of a randomized, double-blind, placebo-controlled study. | Q44782762 | ||
Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis | Q46043948 | ||
Topical NSAIDs for chronic musculoskeletal pain in adults | Q24200809 | ||
Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach | Q24673561 | ||
EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) | Q24674132 | ||
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group | Q28138338 | ||
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial | Q28217835 | ||
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II | Q28396036 | ||
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention | Q29620087 | ||
EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). | Q33260652 | ||
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines | Q33320085 | ||
Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data | Q33516939 | ||
Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications | Q33676719 | ||
Osteoarthritis: new insights. Part 1: the disease and its risk factors. | Q33921631 | ||
Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis | Q34165468 | ||
American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee | Q34273218 | ||
Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association | Q34576407 | ||
Diclofenac topical solution compared with oral diclofenac: a pooled safety analysis | Q35122667 | ||
Clinical comorbidity in patients with osteoarthritis: a case-control study of general practice consulters in England and Wales | Q35553966 | ||
The rate of NSAID-induced endoscopic ulcers increases linearly but not exponentially with age: a pooled analysis of 12 randomised trials | Q35759994 | ||
Pennsaid therapy for osteoarthritis of the knee: a systematic review and metaanalysis of randomized controlled trials | Q36411256 | ||
Long-term tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities | Q36429634 | ||
P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | osteoarthritis | Q62736 |
inflammation | Q101991 | ||
non-steroidal anti-inflammatory drug | Q188724 | ||
anti-inflammatory agent | Q581996 | ||
arthralgia | Q683498 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 27 | |
P577 | publication date | 2014-01-21 | |
P1433 | published in | BMC Musculoskeletal Disorders | Q15751716 |
P1476 | title | Evolving guidelines in the use of topical nonsteroidal anti-inflammatory drugs in the treatment of osteoarthritis | |
P478 | volume | 15 |
Q30401297 | 3D Printing of Scaffolds for Tissue Regeneration Applications. |
Q37292878 | Cross-Sectional Study for Prevalence of Non-Steroidal Anti-Inflammatory Drug-Induced Gastrointestinal, Cardiac and Renal Complications in India: Interim Report |
Q57458498 | Effect of low-intensity long-duration ultrasound on the symptomatic relief of knee osteoarthritis: a randomized, placebo-controlled double-blind study |
Q59809901 | Efficacy Comparison of Five Different Acupuncture Methods on Pain, Stiffness, and Function in Osteoarthritis of the Knee: A Network Meta-Analysis |
Q64063282 | Identification of miRNA Reference Genes in Extracellular Vesicles from Adipose Derived Mesenchymal Stem Cells for Studying Osteoarthritis |
Q47592116 | Intraperitoneal ketorolac for post-cholecystectomy pain: a double-blind randomized-controlled trial |
Q48166311 | Lowering side effects of NSAID usage in osteoarthritis: recent attempts at minimizing dosage. |
Q34459643 | Management of Osteoarthritis with Avocado/Soybean Unsaponifiables. |
Q57300326 | New Approaches to Treat Osteoarthritis with Mesenchymal Stem Cells |
Q39184228 | Onset and durability of pain relief in knee osteoarthritis: Pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxib |
Q64997233 | Patterns of drug treatment in patients with osteoarthritis and chronic low back pain in Japan: a retrospective database study. |
Q38691566 | Skin penetration and tissue permeation after topical administration of diclofenac |
Q38290838 | The effect of COX-2-selective meloxicam on the myocardial, vascular and renal risks: a systematic review. |
Q38265422 | Topical analgesics for neuropathic pain in the elderly: current and future prospects |
Q38551448 | Topical treatment in pain medicine: from ancient remedies to modern usage |
Search more.